Literature DB >> 18347821

Epidemiologic impact of blood culture practices and antibiotic consumption on pneumococcal bacteraemia in children.

A Pérez1, M Herranz, M Segura, E Padilla, F Gil, G Durán, F Ferres, A Esteve, D Blanquer, E Bernaola.   

Abstract

This study examined the roles of two different diagnostic approaches to children with fever of unknown origin in determining the patterns of pneumococcal bacteraemia in two Spanish regions by comparing their main epidemiologic characteristics. Whereas a blood culture is routinely obtained in this setting in Navarre, this is not generally the case in Majorca. Additionally, the potential role of antibiotic consumption in each region was also analysed. Cumulative incidences in children under the age of 14 years were 26.6 per 100,000 child-years in Navarre (121.1 in children <2 years of age) and 7.3 per 100,000 child-years in Majorca (33.3 in children <2 years of age). In contrast, the incidences per 1,000 blood cultures were similar in both regions. The relative risks of occult bacteraemia, bacteraemic pneumonia and meningitis among the children of Navarre compared to Majorcan children were 11.8, 2.6 and 0.8, respectively. The risk for less virulent (vaccine serotypes plus 6A, 19A and 23A) and for more virulent serotypes (1 and 7) was 4.9 and 3.1 times higher in Navarre, respectively. The number of 7-valent pneumococcal conjugate vaccine (PCV7) doses administered between 2003 and 2004 were also higher in Navarre. Conversely, antibiotic resistance and paediatric prescriptions for broad-spectrum antibiotics were greater in Majorca. Although the most salient differences between both regions, including the effectiveness of pneumococcal conjugate vaccine in Navarre, appeared to be confounded by the higher frequency of blood cultures taken there, certain differences in serotype composition may be explained by the higher antibiotic consumption in Majorca.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18347821     DOI: 10.1007/s10096-008-0498-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

1.  Temporary increase in incidence of invasive infection due to Streptococcus pneumoniae in The Netherlands.

Authors:  A J de Neeling; W van Pelt; C Hol; E E Ligtvoet; L J Sabbe; A Bartelds; J D van Embden
Journal:  Clin Infect Dis       Date:  1999-12       Impact factor: 9.079

2.  Will reduction of antibiotic use reduce antibiotic resistance?: The pneumococcus paradigm.

Authors:  Ron Dagan; Galia Barkai; Eugene Leibovitz; Eli Dreifuss; David Greenberg
Journal:  Pediatr Infect Dis J       Date:  2006-10       Impact factor: 2.129

3.  Impact of the pneumococcal conjugate vaccine in the management of highly febrile children aged 6 to 24 months in an emergency department.

Authors:  Santiago Mintegi; Javier Benito; Maria González; Eider Astobiza; Jesus Sanchez; Mikel Santiago
Journal:  Pediatr Emerg Care       Date:  2006-08       Impact factor: 1.454

4.  Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

Authors:  W P Hausdorff; J Bryant; P R Paradiso; G R Siber
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

5.  Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-10-06

Review 6.  Epidemiology of pneumococcal infections in Swedish children.

Authors:  M Eriksson; B Henriques; K Ekdahl
Journal:  Acta Paediatr Suppl       Date:  2000-12

Review 7.  Epidemiological differences among pneumococcal serotypes.

Authors:  William P Hausdorff; Daniel R Feikin; Keith P Klugman
Journal:  Lancet Infect Dis       Date:  2005-02       Impact factor: 25.071

8.  Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.

Authors:  R von Kries; A Siedler; H J Schmitt; R R Reinert
Journal:  Clin Infect Dis       Date:  2000-08-30       Impact factor: 9.079

9.  Trends in antimicrobial resistance in 1,968 invasive Streptococcus pneumoniae strains isolated in Spanish hospitals (2001 to 2003): decreasing penicillin resistance in children's isolates.

Authors:  Jesús Oteo; Edurne Lázaro; Francisco J de Abajo; Fernando Baquero; José Campos
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

10.  Effect of social and climatological factors on antimicrobial use and Streptococcus pneumoniae resistance in different provinces in Spain.

Authors:  César García-Rey; Asunción Fenoll; Lorenzo Aguilar; Julio Casal
Journal:  J Antimicrob Chemother       Date:  2004-07-21       Impact factor: 5.790

View more
  6 in total

Review 1.  Serotype replacement in disease after pneumococcal vaccination.

Authors:  Daniel M Weinberger; Richard Malley; Marc Lipsitch
Journal:  Lancet       Date:  2011-04-12       Impact factor: 79.321

2.  Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar.

Authors:  J Picazo; J Ruiz-Contreras; J Casado-Flores; E Giangaspro; F Del Castillo; T Hernández-Sampelayo; E Otheo; F Balboa; E Ríos; C Méndez
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

3.  Invasive Streptococcus pneumoniae infections in children and older adults in the north of Spain before and after the introduction of the heptavalent pneumococcal conjugate vaccine.

Authors:  E Pérez-Trallero; J M Marimon; M Ercibengoa; D Vicente; E G Pérez-Yarza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-01-20       Impact factor: 3.267

Review 4.  A literature review and survey of childhood pneumonia etiology studies: 2000-2010.

Authors:  Zunera Gilani; Yuenting D Kwong; Orin S Levine; Maria Deloria-Knoll; J Anthony G Scott; Katherine L O'Brien; Daniel R Feikin
Journal:  Clin Infect Dis       Date:  2012-04       Impact factor: 9.079

5.  Methods and challenges for the health impact assessment of vaccination programs in Latin America.

Authors:  Ana Marli Christovam Sartori; Andréia de Fátima Nascimento; Tânia Yuka Yuba; Patrícia Coelho de Soárez; Hillegonda Maria Dutilh Novaes
Journal:  Rev Saude Publica       Date:  2016-01-15       Impact factor: 2.106

6.  Incidence of pediatric invasive pneumococcal disease in the Island of Majorca (2008-2010), an area with non-universal vaccination, and estimations of serotype & children population coverage by available conjugate vaccines.

Authors:  Juan Picazo; Joaquin Dueñas; Antonio Ramirez; Andres-Ricardo Perez; Emma Padilla; Susana Herrero; Carmen Gallegos; Esther Culebras; Cesar Balseiro; Cristina Mendez
Journal:  BMC Infect Dis       Date:  2013-10-29       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.